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Inflammation triggers the differentiation of Ly6Chi
monocytes into microbicidal macrophages or mono-
cyte-deriveddendritic cells (moDCs). Yet, it is unclear
whether environmental inflammatory cuescontrol the
polarization of monocytes toward each of these fates
or whether specialized monocyte progenitor subsets
exist before inflammation. Here, we have shown that
naive monocytes are phenotypically heterogeneous
and contain an NR4A1- and Flt3L-independent,
CCR2-dependent, Flt3+CD11cMHCII+PU.1hi sub-
set. This subset acted as a precursor for FcgRIII+
PD-L2+CD209a+, GM-CSF-dependent moDCs but
was distal from the DC lineage, as shown by fate-
mapping experiments using Zbtb46. By contrast,
Flt3CD11cMHCIIPU.1lo monocytes differentiated
into FcgRIII+PD-L2CD209aiNOS+ macrophages
upon microbial stimulation. Importantly, Sfpi1 hap-
loinsufficiency genetically distinguished the precur-
sor activities of monocytes toward moDCs or micro-
bicidal macrophages. Indeed, Sfpi1+/ mice had
reduced Flt3+CD11cMHCII+ monocytes and GM-
CSF-dependent FcgRIII+PD-L2+CD209a+ moDCs
but generated iNOS+ macrophages more efficiently.
Therefore, intercellular disparities of PU.1 expression
within naivemonocytes segregate progenitor activity
for inflammatory iNOS+ macrophages or moDCs.Immunity 45, 1205–1218, Decem
This is an open access article undINTRODUCTION
Haematopoietic stem cells continually give rise to mononuclear
phagocytes, including monocytes and conventional dendritic
cells (DCs) (Steinman and Cohn, 1973). Both monocytes and
DCs arise from common early bone marrow (BM) myeloid pro-
genitors called MDPs (Fogg et al., 2006; Lee et al., 2015).
MDPs further differentiate into (1) monocyte-committed progen-
itors (cMoPs) (Hettinger et al., 2013), giving rise to Ly6C+
monocytes unable to differentiate into DCs, and (2) common
DC progenitors (CDPs) (Lee et al., 2015; Naik et al., 2007; Onai
et al., 2007), which do not give rise to monocytes but generate
circulating precursors for DCs (pre-DCs) (Breton et al., 2015;
Liu et al., 2009). More recently, MDPs have been shown to
generate granulocytes as well (Sathe et al., 2014).
Initially defined by their ability to drive the priming of naive
T cells after activation (Nussenzweig et al., 1980), DCs are now
regarded as a specific hematopoietic lineage defined by their de-
pendency on growth factor Flt3L (McKenna et al., 2000), which
engages the Flt3 receptor tyrosine kinase (CD135) (Waskow
et al., 2008), and the expression of the transcription factor (TF)
ZBTB46 (Meredith et al., 2012; Satpathy et al., 2012). Fate-map-
ping (Schraml et al., 2013) and barcoding (Naik et al., 2013)
studies have firmly established that DCs are distinct from other
lineages.
Monocytes are BM-derived mononuclear phagocytes that
circulate in the blood stream. In mice, circulating monocytes
are classically defined by expression of CD115 (CSF1R), a re-
ceptor for the macrophage growth factor CSF1 (M-CSF). Two
categories of monocytes have been identified on the basis ofber 20, 2016 ª 2016 The Authors. Published by Elsevier Inc. 1205
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Identification of BM Ly6C+CD115+ Subsets
(A) BM LinMHCIILy6C+CD115+ monocytes consist of three subsets. Shown is a representative flow cytometry analysis of WT BM at steady state. (Top)
Lineage (CD19, CD3ε, Ly6G, Ter119, CD45RA, NK1.1, cKit) MHCII cells analyzed by a conventional monocyte gating strategy. CD115+Ly6Chi cells
can be subdivided into three sub-populations: R1(Flt3CD11c), R2(Flt3+CD11c), and R3(Flt3+CD11c+). (Bottom) Pre-DC gating of LinMHCIICD11c+
Flt3+SIRPaint cells. Pre-DCs can be subdivided into CD115 (P) and CD115+(R3) subsets. Overlay of R3 is shown in green in the lower panels.
(B) Graphical summary of WT andCcr2/mixed BM chimera. Shown are steady-state percentages of WT (CD45.1, white bars) andCcr2/ (CD45.2, black bars)
cells within R1–R3 and P in the BM and blood of WT (CD45.1) reconstituted recipients. Data represent five chimeric mice over two experiments.
(legend continued on next page)
1206 Immunity 45, 1205–1218, December 20, 2016
the expression of Ly6C and CX3CR1 according to GFP intensity
in Cx3cr1GFP/+ mice: Ly6C+CX3CR1int and Ly6CCX3CR1hi
monocytes (Geissmann et al., 2003). Various studies support
the notion that Ly6C+ monocytes can convert to blood Ly6C
monocytes (Hettinger et al., 2013; Sunderko¨tter et al., 2004;
Varol et al., 2007; Yona et al., 2013). However, selective impair-
ment of Ly6C+ monocytes in Irf8/ mutant mice suggests an
independent developmental pathway for Ly6C monocytes
(Kurotaki et al., 2013). The egress of BM Ly6C+ monocytes at
steady state requires the engagement of the chemokine receptor
CCR2 (Serbina and Pamer, 2006). By contrast, most Ly6C
monocytes gain access to the bloodstream independently of
CCR2 and rely on the TFNR4A1 (Hanna et al., 2012). They exhibit
a ‘‘patrolling’’ behavior (Auffray et al., 2007) and scavenge
damaged endothelia during inflammation (Carlin et al., 2013).
A subset of Ly6C monocytes expressing extracellular major
histocompatibility complex II (MHCII) has also been described
(Jakubzick et al., 2013).
Inflammatory monocytes have multiple fates. Pamer and
colleagues have elegantly shown that the sensing of Listeria
monocytogenes (L.m.) infection activates the release of CCR2
ligands to mediate the recruitment of Ly6C+ monocytes, which
differentiate into TNF-a+iNOS+ microbicidal phagocytes (Ser-
bina et al., 2003). iNOS+Ly6C+ phagocytes are distinct from
the DC lineage (Meredith et al., 2012; Satpathy et al.,
2012) and are essential for the control of Listeria infection,
as demonstrated by infection of Nos2/ (MacMicking et al.,
1995), Ccr2/ (Serbina et al., 2003), and monocyte-depleted
(Schreiber et al., 2013) mice.
In addition to differentiating into iNOS+ phagocytes, Ly6C+
monocytes can differentiate into CCR2-dependent monocyte-
derived DCs (moDCs) (Bain et al., 2013; Zigmond et al., 2012).
Accordingly, moDCs can be generated upon adoptive transfer
of Ly6C+ monocytes that progressively lose Ly6C and acquire
MHCII when differentiating in inflamed tissues (Bain et al.,
2013; Zigmond et al., 2012). FcgRI (CD64), FcεRI, and CD206
have emerged as markers of inflammatory phagocytes distinct
from the DC lineage (Cheong et al., 2010; Langlet et al., 2012;
Plantinga et al., 2013).
The processes regulating the polarization of Ly6C+monocytes
toward iNOS+ macrophages or moDCs remain unclear. Local
inflammatory cues might control the nature of monocyte prog-
eny. Alternatively, monocyte subpopulations might be endowed
with a selective potential to generate iNOS+ phagocytes or
moDCs. Here, we report the description and functional charac-
terization of monocyte subsets endowed with the selective abil-
ity to generate iNOS+ phagocytes or moDCs. We show that the(C) Flow cytometry analysis of R1–R3 and P in Flt3l/ and Flt3l+/+ BM and blood
blood (n = 4 mice per group).
(D) qPCR for Zbtb46 in WT BM R1–R3 and P in b-actin units.
(E) Zbtb46 labeling and reporter expression. Steady-state GFP reporter expre
Zbtb46Cre x RosalslYFP mice, respectively.
(F) Genes differentially expressed among R1–R3. Volcano plots of R2 versus R3
(blue) and R3 (red). These genes are overlaid on volcano plots of R1 versus R2
Numbers indicate differentially expressed genes in each comparison (gene list a
(G) Clustering of R1–R3 with pre-DCs and CDPs. Principal-component analysis c
published data of pre-DCs (yellow) and CDPs (violet) on PC1 (72% variance), PC
(H) Hierarchical clustering analysis (1  Pearson correlation) of monocytes (R1 a
Data represent the mean ± SEM (*p < 0.05;**p < 0.005; ns, not significant; Studeamount of PU.1 arbitrates the commitment of monocytes toward
either cell fate.
RESULTS
Ly6C+ Monocytes Are Heterogeneous
As an initial approach to addressing the heterogeneity of BM
mononuclear phagocyte precursors, we analyzed the expres-
sion of CD135 (Flt3) and CD115 (CSF1R) in Lin BM cells (Fig-
ure 1A; isotype controls in Figure S1A). MHCII+ cells were not
considered because they correspond to F4/80hi BM macro-
phages (Figure S1B). We noticed that MHCIICD172a (SIRPa)+
CD115+Ly6C+ cells contained three sub-populations: a major
CD11cFlt3 (R1) and two minor CD11cFlt3+ (R2) and CD11c+
Flt3+ (R3) populations (Figures 1A and S1C). R3 corresponded
phenotypically to a subset of pre-DCs (CD11c+Flt3+SIRPaint;
Liu et al., 2009; Figure 1A) and was distinct from cKit+CD115+
Flt3+ CDPs (Naik et al., 2007; Onai et al., 2007; Figure S1D).
Within pre-DCs, R3 coexisted with CD115 pre-DCs (P) and
aligned with both the Ly6C+SiglecH and Ly6C+SiglecH+
pre-DC subsets (Figure 1A; Schlitzer et al., 2015). R1 and R2
monocytes expressed heterogeneous amounts of CD11b and
CX3CR1 (Figure S1E), had horse-shoe-shaped nuclei (Fig-
ure S1F), and were distinct fromNr4a1-dependent Ly6Clo mono-
cytes (Figure S1G).
Blood LinCD115+Ly6C+ cells, like their Ly6C+ BM counter-
parts, also contained sub-populations R1–R3 (Figures 1B and
1C). R1 expressed higher amounts of CCR2 than R2 and R3 (Fig-
ure S1E), and Ccr2 inactivation drastically restricted the size of
circulating R1 and R2 monocytes, but not pre-DCs (Figure S1H).
Mixed BM chimeras of wild-type (WT) and Ccr2/ cells showed
that CCR2 controls the egress of R1 and R2 monocytes by a
cell-intrinsic effect (Figures 1B and S1I).
Unlike pre-DCs andDCs (McKenna et al., 2000), BMand blood
R1 and R2 cells were largely independent of growth factor Flt3L
(Figure 1C). The DC-specific TF-encoding gene Zbtb46 (BTBD4)
was highly expressed only in R3 and P pre-DCs (Figure 1D).
Accordingly, reporter expression in Zbtb46GFP/+ mice and fate
mapping in the Zbtb46Cre x RosalslYFP model (Loschko et al.,
2016; Figures 1E and S1J) showed that splenic R3 and P pre-
DCs, but not R1 or R2 monocytes, belonged to the DC lineage.
Genes with higher expression in R3 pre-DCs than in R2 mono-
cytes largely overlapped the genes with higher expression in R3
pre-DCs than in R1 monocytes (e.g., Clec9a and Slamf7; Fig-
ure 1F, red dots; Table S1) and, to a lesser extent, overlapped
genes with higher expression in R2 monocytes than in R1 mono-
cytes (Ctsg and Flt3; Figure 1F, red dots in lower left plot). R3. Quantification shows the absolute number of each cell population within the
ssion and YFP expression in splenic R1–R3 and P cells in Zbtb46GFP/+ and
(main plot) show genes with a fold changeR 2 and a p value of p < 0.05 in R2
(left) and R1 versus R3 (right) with the same axes of fold change and p value.
vailable in Table S1).
ompares microarray data of R1 (blue), R2 (red), and R3 (green) with previously
2 (24% variance), and PC3 (2% variance).
nd R2), pre-DCs (R3), total pre-DCs, and CDPs.
nt’s t test). Please also refer to Figure S1.
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Figure 2. Transcriptional Profiling of Monocyte Subsets R1 and R2
(A) Nonlinear dimensionality reduction analysis of Ly6ChiCD115+cells. t-SNE maps of total LinMHCIICD115+SIRPa+ cells, R1 and R2 monocytes, and R3 pre-
DCs are based on the parameters CD115, SIRPa, Ly6C, Flt3, CD11c, CD209a, and FcgRII and/or FcgRIII. Color scale indicates Flt3 expression.
(B) Expression analysis of t-SNE-generated sub-populations of R2 and expression of Flt3, FcgRII and/or FcgRIII, CD209a, CD11b, CD11c, Ly6C, and CD115 of
t-SNE-generated Flt3+ populations A–C with R1 monocytes. CD209a expression is shown as the difference between MFI and fluorescence minus one (FMO)
control for all four populations.
(legend continued on next page)
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pre-DCs expressed genes belonging to the DC signature (Miller
et al., 2012) (e.g., Clec9a and Slamf7; Figures 1F and S1K) and
clustered with total pre-DCs and CDPs (Figures 1G and 1H).
Genes with higher expression in R2monocytes than in R3 pre-
DCs (Figure 1F, blue dots in the main panel) largely overlapped
the genes with higher expression in R1 monocytes than in
R3 pre-DCs (e.g., Msr1 and Fcgr3; Figure 1F, lower right plot;
Table S1). However, most of these genes were not differentially
expressed between R2 and R1 monocytes (Figure 1F, blue
dots in lower left panel). Furthermore, R1 and R2 expressed a
macrophage signature (e.g., Fcgr3 and Csf3r; Figure S1K; Gaut-
ier et al., 2012) while clustering close to each other (Figures 1G
and 1H) apart from the DC-committed precursors.
Overall, R1 and R2 were more similar to each other than to R3
(Figures 1F–1H; Table S1). We conclude that R1 and R2 qualify
as bona fidemonocytes given that both are largely CCR2 depen-
dent for BM egress, do not rely on Flt3L, and do not express
Zbtb46. R3 met all the criteria for bona fide pre-DCs because it
was largely CCR2 independent and Flt3L dependent and ex-
pressed the DC-specific Zbtb46 (Meredith et al., 2012; Satpathy
et al., 2012).
R2 Monocytes Bear a Mixed Transcriptional Profile
We next aimed to assess the diversity of Ly6C+ monocytes
by using unsupervised analyses. To this end, we used multi-di-
mensional reduction analysis of multi-parametric flow cytome-
try. BM Ly6C+CD115+ cells were divisible into one major Flt3
and three minor Flt3+ subsets with distinct t-distributed stochas-
tic neighbor embedding (t-SNE) coordinates (populations A–C)
(Figure 2A). Population A was CD11c and found only within
R2. By contrast, populations B and C overlapped R2 and R3. Un-
like population C, A andB phenotypically shared high expression
of FcgRII and/or FcgRIII with R1 monocytes. However, like pop-
ulation C but unlike R1 monocytes, A and B expressed CD209a
(Figure 2B). All together, these data were corroborated bymicro-
array analysis of BM R1–R3 populations (Figure S2A) and flow
cytometry analysis of blood Ly6C+ cells (Figure S2B). In addition,
population C had lower CD11b expression than A and B
(Figure 2B).
As a parallel unsupervised approach, we used gene-expres-
sion profiling at the single-cell level to assess the diversity of
Ly6C+CD115+ cells. We performed single-cell qPCR by using a
set of 42 genes and 3 house-keeping controls. Unsupervised
clustering of gene expression at the single-cell level revealed
the existence of five clusters within Ly6C+CD115+ cells (Fig-
ure 2C). Clusters 1 and 2 alignedmostly with R1 and also partially
with R2. Cluster 3 was exclusively represented within R2,
whereas clusters 4 and 5 were enriched in R3 but also present
in R2 (Figures 2C–2E). Cluster 3 was unique in its mixed expres-
sion pattern of monocyte (Fcgr3, Fcgr2b, and Csf3r) and DC(C) Heterogeneity in population R2. The hierarchical clustering dendogram (top and
of 44 R1 (blue), 81 R2 (red), and 44 R3 (green) single cells for 42 genes.
(D) Representation of populations R1–R3 within the five clusters defined in (C).
(E) Representation of the five clusters within populations R1–R3.
(F) Single-cell expression of Fcgr3, CD209a, and Zbtb46 in populations R1–R3 o
(G) Analysis of the defining genes of population R1 with clusters C3–C5. The he
Cd209a, and Fcgr2 and/or Fcgr3 on single cells between clusters C3–C5 and m
Please also refer to Figure S2.(Kmo, Cd209a, and Flt3) genes (Figures 2C and 2F and S2A
and S2B). However, cluster 3 (in addition to clusters 1 and 2)
showed low transcription of Zbtb46, which was found in clusters
4 and 5 (Figure 2F).
Of interest, we noticed that the expression of Ciita and MHCII-
related genes was found mostly in clusters 3 and 5 (Figure S2C).
This is consistent withMHCII expression in BMand blood R2 and
R3, as assessed by flow cytometry and microarray analysis (Fig-
ures S2D and S2E). R2 and R3 thus aligned with previously
described Ly6C+CD115+MHCII+ cells in the blood (Carlin et al.,
2013; Jakubzick et al., 2013; Figure S2F). Using mice deficient
of various CIITA promoters (pI/, pIV/, or pIII+pIV/), we
showed that R2, like DCs, expressed MHCII after pI-dependent
induction of Ciita (LeibundGut-Landmann et al., 2004; Figures
S2G and S2H).
All together, both unsupervised flow cytometry and gene-
expression analyses revealed that R2 monocytes contained
unique populations of Zbtb46 cells that were distinct from the
cDC lineage and expressed transcriptional profiles with mixed
features of monocytes and cDCs (Zbtb46Flt3+FcgRII and/or
FcgRIII+CD209a+CD11c). Using MHCII as a surrogate marker
for these cells, we showed that they are independent of Flt3L
and rely on CCR2 for their mobilization from the BM to the blood
(Figures S2I and S2J).
PU.1 Controls the Formation of Flt3+MHCII+ R2
Monocytes
We next sought to identify TFs regulating the formation of
R2 Flt3+MHCII+ monocytes. Sfpi1 (PU.1) is an attractive candi-
date because it promotes Flt3 expression (Carotta et al., 2010)
and MHCII through the induction of Ciita (Bakri et al., 2005).
Intracellular flow cytometry staining for PU.1 indicated that
R3 pre-DCs and R2 monocytes expressed higher amounts of
PU.1 than R1 monocytes (Figure 3A). Accordingly, PU.1 was
expressed more in MHCII+ than in MHCII blood CD115+ cells
(Figure 3B).
The effects of PU.1 were tightly dependent on its expression;
therefore, we analyzed Sfpi1+/ mice that had reached
adulthood without any obvious phenotype. Sfpi1+/ mice had
reduced numbers of blood CD115+Ly6Clo cells, whereas blood
Ly6C+ were not affected despite an increase in BM Ly6C+ cells
(Figure 3C). Sfpi1+/ mice had reduced MHCII+ (Ly6C+ and
Ly6C) CD115+ populations in the BM and blood (Figure 3D).
Finally, Sfpi1+/ mice had smaller populations of R2 monocytes
(including the MHCII+ fraction of R2) and R3 pre-DCs than WT
mice in BM and blood (Figures 3E and S3A–S3C). In agreement
with R3 pre-DC reduction, Sfpi1+/ mice displayed a selective
deficiency in spleen CD11b+ DCs, mostly in the ESAM1loFlt3lo
compartment, whereas plasmacytoid DCs remained unchanged
(Figures S3D–S3F). In contrast to R2 monocytes and R3left margins) is based onDCt values from single-cell multiplex qPCRanalysis
r clusters C1–C5. Each dot represents the DCt value of a single cell.
atmap compares mRNA expression of MHCII-related genes Cd135, Zbtb46,
onocyte population R1.
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Figure 3. PU.1 Controls the Development of
PU.1hiFlt3+MHCII+ R2 Monocytes at Steady
State
(A and B) Expression of PU.1 (black shading)
and isotype control (gray shading) within
Ly6ChiCD115+ monocytes (R1 and R2) and pre-
DCs (R3) (A) and in Ly6ChiMHCII, Ly6C+MHCII+,
and Ly6CMHCII+CD115+ cells (B) in the blood as
seen by intra-nuclear staining of PU1 by flow
cytometry. Numbers within plots indicate the MFI
of PU.1.
(C–E) Representative flow cytometric analysis of
the blood of Sfpi1+/+ and Sfpi1+/ mice at steady
state. (C) Comparison of total (SIRPa+CD115+),
Ly6C+, and Ly6Clo blood monocytes by flow cy-
tometry and quantification as the percentage of
total live cells. (D and E) Comparison of Ly6C+
MHCII, Ly6C+MHCII+, and Ly6CMHCII+ cells
within SIRPa+CD115+ monocytes (D) and of R1–
R3 within Ly6Chi MHCII+/ monocytes (E) in the
BM and blood. Gray bars indicate intracellular
staining for MHCII.
Data represent the mean ± SEM of three mice per
group from three identical experiments (*p <
0.05,**p < 0.005, ***p < 0.0005; Student’s t test).
Please also refer to Figure S3.pre-DCs, R1 monocytes were slightly increased in the BM of
Sfpi1+/ mice (Figure 3E). However, this increase did not reach
significance in the blood (Figures 3E, S3A, and S3B). Sfpi1 hemi-
zygosity reduced the numbers of MDPs and CDPs, but not
cMoPs (Figure S3F). We conclude that high expression of PU.1
is selectively required for the development of Flt3+MHCII+ R2
monocytes and R3 pre-DCs at steady state.
PU.1loFlt3–MHCII– R1 Monocytes Generate iNOS+
Macrophages upon Microbial Stimulation
In the next set of experiments, we aimed to determine which
Ly6C+ monocytes are precursors for iNOS+ macrophages. We
chose to use Listeria infection because it efficiently induces the
recruitment and differentiation of iNOS+ phagocytes from
Ly6C+ monocytes (Serbina et al., 2003). In agreement with their
independence of Flt3L (Meredith et al., 2012), L.m.-induced
iNOS+macrophages were not identified in Zbtb46crexROSAlslYFP
mice (Loschko et al., 2016), thus confirming their monocytic
origin (Figure S4A). In vitro exposure to lipopolysaccharide
(LPS) or infection with L.m. resulted in iNOS expression in a
subset of responding BM CD115+Ly6C+ cells (up to 38%) that1210 Immunity 45, 1205–1218, December 20, 2016remained mostly MHCIIlo (Figure 4A), un-
less these cells were treated with inter-
feron-g (IFN-g), which increased MHCII
expression in iNOS+ cells (Figure S4B).
Overnight culture of sorted R1 or R2
monocytes or R3 pre-DCs with L.m. or
LPS (Figures 4B and S4C) revealed the
selective ability of R1 to produce iNOS+
MHCII macrophages, whereas R2 and
R3 generated iNOSMHCII+ cells (Fig-
ures 4B and S4C). We conclude that the
formation of iNOS+ macrophages uponmicrobial exposure is a selective feature of R1 monocytes or
possibly a subset of them. Like R1 monocytes (Figures 2F and
2G), in-vivo-generated Ly6C+CD11b+iNOS+ macrophages (Ser-
bina et al., 2003) expressed FcgRII and/or FcgRIII, but not
CD209a or Flt3 (Figure 4C).
Transcriptomic analysis of BM R1–R3 demonstrated an upre-
gulation of toll-like receptor (TLR) signaling, RIG-like helicase,
NOD-like receptor genes, and IFN-g signaling and its target
genes in R1 monocytes (Figure 4D). We conclude that R1 cells
are efficiently equipped for innate sensing prior to microbial
exposure.
We next wanted to determine whether iNOS+ macrophages
lose iNOS and enter a differentiation pathway of monocytes
characterized by the loss of Ly6C in inflamed tissues (Bain
et al., 2013; Zigmond et al., 2012). We used a fate-map-
ping approach to irreversibly label iNOS-expressing cells in
Nos2tomato-crexROSAlsltdTomato mice. L.m. infection triggered the
labeling (Tomato+) of a subset of Ly6C+ cells 2 days after infec-
tion; these cells were also stained with anti-iNOS antibody (Fig-
ures 4E, 4F, and S4D). We found that by day 4, the iNOS+ cells
(both Tomato+ and anti-iNOS-Ab+ cells) had reduced drastically
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Figure 4. Pu.1loFlt3–MHCII– R1 Monocytes
Differentiate into iNOS+ Phagocytes upon
Microbial Stimulation
(A) iNOS production by CD115+ cells in vitro.
Shown is surface MHCII and intracellular iNOS or
isotype control (Iso iNOS) staining after overnight
culture of BM LinCD115+ cells in the presence of
LPS or L.m. (MOI = 0.1).
(B) In vitro microbial stimulation of R1–R3. Shown
is the analysis of surface MHCII and intracellular
iNOS on sorted R1–R3 cells cultured overnight in
the presence of LPS (1 mg/ml).
(C) Cell-surface phenotype of LinCD11b+iNOS+
cells during L.m. infection (day 2). Shown is flow
cytometry analysis of CD209a, FcgRII and/or
FcgRIII (CD16/32), and Flt3 (black lines) against
respective isotype controls (gray shading).
(D) Pathway analysis of differentially expressed
genes in flow-cytometry-sorted steady-state BM
R1–R3. Abbreviations are as follows: TLR, toll-like
receptor; RLH, RIG-like helicase; NLR, NOD-like
receptor; IFN, interferon; and ISG, interferon-
stimulated gene.
(E–H) Fate mapping of L.m.-induced iNOS-
expressing splenocytes. (E) Nos2TomatoCre x
RosalsltdTomato mice infected with the DActA
mutant of L.m. were analyzed for intracellular anti-
iNOS staining (top) and tomato labeling (bottom) in
LinCD11b+ splenocytes in control or L.m.-in-
fected mice (days 2 and 4). (F) Mean ± SEM of
the percentage of iNOS-Ab+ (top) and Tomato+
(bottom) cells in Bl/6 (WT) or Nos2TomatoCre x
RosalsltdTomato mice in untreated (d0) or L.m.-in-
fectedmice on days 2 and 4 (n = 3). (G) Histograms
show Ly6C expression in cells either stained or
unstained with anti-iNOS antibody or iNOS-To-
mato. (H) Percentages of Ly6C+ cells within each
indicated population (n = 4 mice per group; **p <
0.005,***p < 0.0005, ****p < 0.00005; Student’s t
test).
Please also refer to Figure S4.(Figure 4F). Like iNOS-Ab+ cells, tomato+ cells remained Ly6C+
and did not become Ly6C (Figures 4G and 4H). Therefore, we
conclude that Ly6C+iNOS+ macrophages do not convert effi-
ciently to Ly6C. This result is compatible with the existence of
a subset of Ly6C+ monocytes specialized to generate iNOS+
macrophages.
High Amounts of PU.1 Inhibit the Production of iNOS+
Macrophages
From the experiments performed so far, we noticed that PU.1
concentration was inversely correlated with the ability of mono-
cyte subsets to generate iNOS+ macrophages (Figures 3A and
4B). We therefore hypothesized that PU.1 acts as a regulator
of iNOS expression. To test this hypothesis, we infected WT
and Sfpi1+/ mice with L.m. and analyzed the generation of
CD11b+Ly6C+iNOS+ macrophages in the spleens of these ani-
mals 2 days later. Using the avirulent DActA mutant of L.m., we
were able to assess innate sensing of the bacteria independently
of infectious load (Schreiber et al., 2013; Serbina et al., 2003).Sfpi1+/ mice accumulated higher numbers of total CD11b+
Ly6C+ and CD11b+Ly6C+iNOS+ macrophages than did their
WT counterparts (Figures 5A–5C). Importantly, the percentage
of iNOS+ cells in Ly6C+CD11b+ macrophages was increased in
Sfpi1+/ mice, whereas MHCII expression remained unchanged
(Figures 5C and S5A).
In order to test whether the regulatory role of PU.1 is cell
intrinsic, we infected normalized numbers of BM macro-
phages (BMDMs) from WT or Sfpi1+/ mice infected with
L.m. (or LPS) overnight. We found that Sfpi1+/ macrophages
expressed higher amounts of iNOS than did WT cells both
in percentage and staining intensity (Figures 5D and S5B).
We conclude that Sfpi1 acts as a negative regulator of
iNOS acquisition in monocytes responding to microbial
stimulation.
In order to address the cell-intrinsic role of PU.1 in vivo, we
performed adoptive transfers of CD45.2+Sfpi1+/+or CD45.2+
Sfpi1+/BM cells into L.m.-infected CD45.1+ recipients. Sfpi1+/
donor cells expressed more iNOS than their WT counterpartsImmunity 45, 1205–1218, December 20, 2016 1211
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Figure 5. PU.1 Inhibits the Generation of
iNOS+ Macrophages upon Microbial Stimu-
lation
(A–C) Generation of Ly6C+iNOS+ cells upon mi-
crobial stimulation of Sfpi1+/+ or Sfpi1+/ mice.
(A) Intracellular flow cytometry staining of spleen
Lin (CD19, CD3ε, Ly6G, Ter119, CD45RA,
NK1.1, cKit) CD11b+ cells in Sfpi1+/+ and
Sfpi1+/ mice infected with DActA L.m. (B and C)
Quantification of the percentage and absolute
number of LinCD11b+Ly6C+ cells (B) and
LinCD11b+iNOS+ cells (C).
(D) Microbial stimulation of BMDMs generated
from Sfpi1+/+ or Sfpi1+/ mice and flow cytometry
analysis of iNOS+ BMDMs from Sfpi1+/+ and
Sfpi1+/ mice. BMDMs were cultured with MCSF
alone,MCSF and L.m. at aMOI of 1 or 10, orMCSF
and 1 mg/ml LPS. Numbers at the top of each gate
indicate MFI. The percentage of iNOS+ cells
obtained within each culture is quantified.
(E) PU.1 reduction in the BM compartment results
in an increase in iNOS+ macrophages in vivo.
CD45.2+Sfpi1+/+ or Sfpi1+/ whole BM was
adoptively transferred into WT DActA L.m.-in-
fected CD45.1+ recipients. Representative flow
cytometry analysis of iNOS expression in
LinCD11b+Ly6C+ splenocytes from recipients
(CD45.1+) or donors (CD45.2+) is shown.
(F) PU.1 in monocytes regulates the production
of iNOS+ macrophages in vivo. Shown is flow
cytometry analysis of iNOS expression in
LinCD11b+Ly6C+ cells of CD45.1+Sfpi1+/+ and
CD45.2+Sfpi1+/ sorted BMmonocytes adoptively
transferred intravenously into WT DActA L.m.-in-
fected CD45.1/.2+ recipients (n = 4 mice per
group).
Data represent the mean ± SEM (*p < 0.05; **p <
0.005; ***p < 0.0005; ns, not significant; Student’s
t test). Please also refer to Figure S5.(Figure 5E). Finally, to address the role of Sfpi1 in the monocyte
compartment, we engrafted a mixture of Sfpi1+/ (CD45.2) and
Sfpi1+/+ (CD45.1) BM monocytes into L.m.-infected CD45.1
and CD45.2 recipient mice. We found that the percentage of
iNOS+ macrophages within Ly6C+CD11b+ cells was higher in
the progeny of Sfpi1+/monocytes than in that of Sfpi1+/+ mono-
cytes (Figure 5F).
We conclude that PU.1 acts as a cell-intrinsic negative regu-
lator of the differentiation ofmonocytes into iNOS+macrophages
upon microbial exposure.
PU.1hiFlt3+MHCII+ R2 Monocytes Differentiate into
PDL2+CD209a+ moDCs upon GM-CSF Exposure
Having established that R1 monocytes are poised to generate
iNOS+ macrophages, we next assessed the ability of mono-
cyte subsets to give rise to moDCs. Elevation of granulo-
cyte-macrophage colony-stimulating factor (GM-CSF) concen-
trations induces the accumulation of CD11b+MHCII+ spleen
cells that resemble CD11b+ DCs (Daro et al., 2000; Mach
et al., 2000). Engraftment of live GM-CSF-producing B161212 Immunity 45, 1205–1218, December 20, 2016melanoma (B16-GM-CSF) (Dranoff et al., 1993) triggered
the expansion of (1) circulating MHCII+ monocytes with
varying expression levels of Ly6C (Figure S6A) and (2)
LinLy6GCD11b+Ly6Chi–loMHCII+ spleen cells largely over-
lapping the CD11b+ DC phenotype (Figure S6B). GM-CSF-
induced (or LPS-induced; Figure S6C) Ly6Chi–loMHCII+ cells
can be subdivided according to their expression of FcgRII
and/or FcgRIII and CD209a (Figures 6A and 6B). Both
CD209a and CD209a+ FcgRII+ and/or FcgRIII+ populations
rely on CCR2 (Figure S6D). Compared with CD4+ DCs,
CD209a and CD209a+ FcgRII+ and/or FcgRIII+ cells ex-
pressed greater CD115 and lower Flt3 and ESAM1 (Fig-
ures 6B and S6E). In stark contrast with CD4+CD11b+ DCs
(Figures 6B and S6E), both expressed PD-L2 and low amounts
of PD-L1 (Figures 6B and S6C). Additionally, both CD209a
and CD209a+ FcgRII+ and/or FcgRIII+ cells had lower expres-
sion of YFP than CD4+ DCs from naive or B16-GM-CSF-
bearing Zbtb46Cre x RosalslYFP mice (Loschko et al., 2016; Fig-
ures 6B and S6F). A similar hierarchy of labeling was obtained
in the Zbtb46GFP/+ reporter mice (Satpathy et al., 2012;
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Figure 6. PU.1hiFlt3+MHCII+ R2 Monocytes
Differentiate into PD-L2+CD209a+ moDCs
upon Exposure to GM-CSF
(A) Phenotype of spleen cells from control, B16, or
B16-GM-CSF-engrafted mice. FACS analysis for
CD4, Ly6C, FcgRII and/or FcgRIII, and CD209a
expression within Lin (Ly6G, CD3ε, NK1.1,
Ter119, CD45RA, cKit) CD11b+MHCII+ spleen
cells in naive, B16, or B16-GM-CSF-bearing
mice. Absolute numbers of CD4FcgRII+ and/or
FcgIII+CD209a, CD4FcgRII+ and/or FcgIII+
CD209a+, and CD4+ cells in LinCD11b+MHCII+
cells in spleens from B16-GM-CSF-engrafted
mice. Data are normalized to the naive control of
each population.
(B) Phenotype of CD4FcgRII+ and/or FcgIII+
CD209a, CD4FcgRII+ and/or FcgRIII+CD209a+,
and CD4+ cells in LinLy6GCD11b+MHCII+
splenocytes from B16-GM-CSF-bearing mice.
Extracellular flow cytometry analysis of each
population is shown for CD115, PDL2 (CD273),
PDL1 (CD274), Flt3, ESAM1, and MHCII (black)
against isotype controls (gray). YFP labeling of the
indicated populations in Zbtb46Cre x RosalslYFP
mice and GFP labeling in Zbtb46GFP/+ mice is
also shown. Numbers above the histograms indi-
cate MFI. Data represent five mice over two
experiments.
(C) GM-CSF culture of flow-cytometry-sorted
R1 and R2 BM monocytes. Shown is PDL2
and CD209a expression on DAPICD45+ cells
after 2 days of culture and MHCII expression
of CD209a (gray) and CD209a+ (black). Data
represent three independent cultures.
(D) Cell fate of flow-cytometry-sorted R1 or R2 BM
monocytes adoptively transferred into B16-GM-
CSF-engrafted mice. Shown is FcgRII and/or
FcgRIII and CD209a expression on recipient
CD45.1+ (Figure S6G) and donor CD45.2+ cells in
the spleens of CD45.1+ B16-GM-CSF-bearing re-
cipients, as well as quantification of CD209a+ cells
within LinCD11b+MHCII+CD4CD45.2+ cells.
Data represent the mean ± SEM (*p < 0.05; **p <
0.005; ***p < 0.0005; ns, not significant; Student’s
t test). Please also refer to Figure S1.Figure 6B). Together, these results support a monocytic origin
of CD209a and CD209a+ FcgRII+ and/or FcgRIII+ cells.
Finally, we addressed whether R1 and/or R2 BM mono-
cytes could differentiate into PDL2+CD209a+ cells upon
short-term culture in GM-CSF. We found that, reminiscent
of macrophages produced during long-term GM-CSF culture
(Barthe´le´my et al., 2015), R1 cells produced exclusively
CD209aMHCIIloPDL2+ cells. Unlike R1, R2 monocytes
produced CD209a+MHCIIhiPDL2+ cells (Figure 6C). In vivo,
adoptive transfer of R2, but not R1, monocytes in
B16-GM-CSF-engrafted mice generated CD209a+ moDCs,
as was seen in the CD45.1+ recipients (Figures 6D and
S6G). We conclude that R2, but not R1, monocytes exhibit
a precursor ability for CD209a+PDL2+ moDCs in vitro and
in vivo.An Increase in PU.1 Promotes the Generation of
Monocyte-Derived PDL2+CD209a+ moDCs
Finally, we investigated whether a higher expression of PU.1 is
required for the differentiation of GM-CSF-induced moDCs.
The generation of PD-L2hiCD86hiMHCIIhi moDCs (Barthe´le´my
et al., 2015; Gao et al., 2013) from BM GM-CSF cultures was
lower in Sfpi1+/ cultures than in WT cultures (Figure S7A). WT,
but not Sfpi1+/ Ly6Chi, monocytes generated PD-L2+CD209a+
moDCs in vitro (Figure 7A). Analyzing B16-GM-CSF-engrafted
Sfpi1+/+ or Sfpi1+/ mice, we found that the expansion of
CD209a+ moDCs (but not FcgRII+ and/or FcgRIII+ CD209a
macrophages) was selectively decreased in Sfpi1+/ mice
(Figure 7B).
We wondered whether PU.1 is required at the cell-autono-
mous level for the generation of CD209a+moDCs.We adoptivelyImmunity 45, 1205–1218, December 20, 2016 1213
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Figure 7. PU.1 Promotes the Generation of GM-CSF-Dependent PD-L2+CD209a+ moDCs
(A) FcgRII and/or FcgRIII and CD209a expression in GM-CSF culture of BM LinCD115+Ly6C+ cells from Sfpi1+/+ or Sfpi1+/ mice. FcgRII+ and/or FcgRIII+
CD209a (blue) and FcgRII+ and/or FcgRIII+CD209a+ (red) cells are overlaid on flow cytometry staining of PDL2 (CD273) andMHCII. The percentage and absolute
number of DAPICD45+ cells of each indicated population of Sfpi1+/+ or Sfpi1+/ BM are shown. Data represent two similar experiments.
(B) Quantification of FcgRII+ and/or FcgRIII+CD209a and FcgRII+ and/or FcgRIII+CD209a+ cells in LinCD11b+MHCII+CD4 splenocytes from B16-GM-CSF-
bearing Sfpi1+/+or Sfpi1+/ mice. Data represent six mice.
(C) PU.1 promotes the generation of CD209a+ moDCs by a cell-intrinsic mechanism. Shown is the adoptive transfer of CD45.2+ Sfpi1+/+ or Sfpi1+/ BM into B16-
GM-CSF-engrafted CD45.1+ congenic recipients, as well as CD209a and FcgRII and/or FcgRIII expression on LinCD11b+MHCII+CD4 cells of recipient
CD45.1+ or donor CD45.2+ Sfpi1+/+ or Sfpi1+/ BM. The percentage of CD209a+ cells inside the donor LinCD11b+MHCII+CD4FcgRII+ and/or FcgRIII+CD45.2+
cells is quantified (n = 3 mice per group in two identical experiments). Data represent the mean ± SEM (*p < 0.05, **p < 0.005, ***p < 0.0005; Student’s t test).
Please also refer to Figure S7.transferred Sfpi1+/+ or Sfpi1+/ CD45.2+ BM into CD45.1+ B16-
GM-CSF-injected recipients. Unlike Sfpi1+/+BM, Sfpi1+/ BM
did not generate CD209a+ moDCs (Figure 7C). Control popula-
tions such as B cells and granulocytes were generated as
efficiently upon transfer of either Sfpi1+/+ or Sfpi1+/ BM
(Figure S7B). We conclude that PU.1 selectively controls the
differentiation of GM-CSF-dependent CD209a+ moDCs by a
cell-intrinsic mechanism.1214 Immunity 45, 1205–1218, December 20, 2016DISCUSSION
Depending on the study, monocyte-derived inflammatory cells
(distinct from the cDC lineage) are termed inflammatory macro-
phages (Bain et al., 2013; Tamoutounour et al., 2012) or moDCs
(Cheong et al., 2010; Plantinga et al., 2013; Zigmond et al., 2012).
Here, we report that distinct monocyte subsets give rise
to iNOS+ inflammatory macrophages and CD209a+ moDCs.
Indeed, we have shown that a subset of monocytes (R2; CCR2
dependent and not labeled in Zbtb46Cre x RosalslYFP mice)
contain MHCII+ cells that are distinct from BTBD4+ pre-DCs.
These cells develop into CD209a+ moDCs upon exposure to
GM-CSF both in vitro and in vivo. Conversely, MHCII mono-
cytes (R1) possess the progenitor function for iNOS+ inflamma-
tory macrophages. This supports the view that inflammatory
macrophages and moDCs are ontogenically distinct popula-
tions. In support of this hypothesis, fate mapping of iNOS+ in-
flammatory macrophages did not show an efficient conversion
to the moDC phenotype. In addition, single-cell analysis of
monocytes (R2; CD11c) identified a mixed transcriptional pro-
gram characterized by the expression of MHCII genes (down-
stream activation of CIITA by pI promoter) and DC-related genes
such as Flt3, Cd209a, or Kmo, for example. These cells might
originate from cMoPs (through Flt3 acquisition), from CDPs
(via loss of DC-specific commitment), or from earlier myeloid-
primed progenitors (LMPP or GMPs). Additional experiments
are needed to address this. Of note, we have shown that
R3 cells (CD11c+Flt3+CD115+BTBD4+SiglecHLy6C+) aligning
with previously described cDC2-commited pre-cDCs (pre-
DC2s) (Schlitzer et al., 2015; Tussiwand et al., 2015) are diverse
in terms of MHCII or CD209a expression, for example. The func-
tional relevance of pre-DC2 heterogeneity for the generation of
multiple cDC2 subsets (Lewis et al., 2011; Tussiwand et al.,
2015) remains to be addressed.
An important question that arises is the transcriptional
mechanism driving the steady-state differentiation of Ly6C+
monocytes into a small sub-population with a distinct potential
to generate moDCs or inflammatory macrophages. PU.1 is a
lineage-determining TF essential for hematopoietic stem cells
and has multiple roles in the myeloid lineage (Dakic et al.,
2005; DeKoter and Singh, 2000; McKercher et al., 1996; Scott
et al., 1994). PU.1 cooperates with multiple other TFs to shape
the enhancer landscape of tissue-resident macrophages
(Lavin et al., 2014; Norris et al., 2014). Here, we report that
Sfpi1 haploinsufficiency promotes the generation of iNOS+
macrophages during L.m. infection. PU.1-dependent negative
regulation of iNOS+ macrophages might constitute a regula-
tory mechanism limiting iNOS-dependent immunopathology.
How does PU.1 downregulate the production of iNOS? PU.1
is known to upregulate multiple miRNAs, including miR-146
and miR-155, which in turn negatively regulate innate sensing
through the regulation of TRAF6, IRAK4, and STAT1, for
example (Ghani et al., 2011; Jurkin et al., 2010). Indeed,
Ly6C+ monocytes from mir146/ mice are hyper-responsive
to microbial stimulation (Etzrodt et al., 2012). Higher amounts
of PU.1 might be needed to induce mir146 and limit anti-mi-
crobial responses. Further experiments are needed to assess
the relevance of miRNAs downstream of PU.1-dependent
regulation of innate sensing.
We have found that, in addition to having a regulatory effect on
microbicidal iNOS+ macrophages, the highest amounts of PU.1
selectively promote the generation of GM-CSF-dependent
moDCs in vitro and in vivo. This could be explained by (1) the
reduction of moDC precursors (MHCII+ R2 monocytes) in naive
Sfpi1+/ mice and (2) an effect on moDC terminal differentiation.
In support of the latter, overexpression of PU.1 promotes the dif-
ferentiation of DC-like cells (Bakri et al., 2005), and inducibleablation of Sfpi1 prevents the differentiation of DCs (Carotta
et al., 2010). In this context, PU.1 cooperation with TFs IRF4
and IRF8 could be relevant to explain the role of PU.1 in moDC
differentiation from monocytes. PU.1 can bind to Ets binding
sites on its own, but PU.1 also cooperates with IRF4 or IRF8 at
Ets-IRF composite response elements called EICEs (Brass
et al., 1999). IRF4 is known to be involved in the control of CIITA
promoter pI in GM-CSF moDCs or CD11b+ DCs (Gao et al.,
2013; Tamura et al., 2005; Vander Lugt et al., 2014). In addition,
PU.1 might boost the expression of growth factor receptors
required for the development of moDCs (e.g., CSFR2A; DeKoter
et al., 1998).
In conclusion, our results shed light on the readiness of
inflammatory monocyte subsets for distinct and specialized
developmental programs activated in inflammatory conditions.
Importantly, PU.1 amounts segregate the transcriptional pro-
grams of microbicidal iNOS+ macrophages or moDCs.
EXPERIMENTAL PROCEDURES
Mice
All mice usedwere between 6 and 12weeks old andwerematched for age and
sex in all experiments. They were maintained under specific-pathogen-free
conditions in accordance with the UK Animals (Scientific Procedures) Act of
1986.
Cell Isolation and Fluorescence-Activated Cell Sorting
For preparation of BM cell suspensions, the bones of both hind limbs (two
tibia and two femurs) were flushed with ice-cold fluorescence-activated cell
sorting (FACS) buffer (PBS (Life technologies) with 1% BSA (Apollo Scienti-
fic Ltd) and 2 mM EDTA (Life Technologies). Spleens were collected, cut
into small pieces, and incubated with collagenase D (Roche) and DNaseI
(Roche) in Hank’s balanced salt solution (GE Healthcare) and 5% fetal
bovine serum (Life technologies) for 20 min; they were further macerated
through 100 mm cell strainers (BD Falcon). Red blood cells were lysed
with 2 ml of Ack lysis buffer (Life Technologies), incubated for 2 min at
room temperature, and then diluted with FACS buffer. After centrifugation,
cells were either re-suspended in an antibody cocktail in FACS buffer or
permeabilized and fixed for intracellular staining and analyzed by flow cy-
tometry with FlowJo software (TreeStar). For cell sorting, see Supplemental
Experimental Procedures.
In Vitro GM-CSF Cultures
Total BM or 104 sorted Ly6ChiCD115+ monocytes (total or subsets R1–R3)
were cultured in 20 ng/ml of GM-CSF in complete RPMI with 6,000 live
MS-5 cells as ‘‘feeders,’’ which were plated on the same day. Analyzed cells
were pre-gated to be DAPI and CD45+.
In Vitro L.m. Infections
Primary cells infected with L.m. were in vivo cultured overnight at an MOI of
0.01, 0.1, 1, or 10 (as indicated in Figure 5) in complete RPMI medium supple-
mented with macrophage colony-stimulating factor (MCSF, 20 ng/ml; Pepro-
tech), GM-CSF (3 ng/ml; Peprotech), and human Flt3L (100 ng/ml; CellDex).
BMDMs were derived by culture of whole BM in RPMI supplemented with cul-
ture medium from L-929 cells.
B16-GM-CSF Tumor Experiments
B16-GM-CSF tumor cells were checked for viability with Trypan Blue, and
1.53 105 to 33 105 live cells were injected subcutaneously (see Supplemental
Experimental Procedures).
Infection
4 3 103 to 5 3 103 WT colony-forming units (CFU) (Listeria) or 106 DActA
mutant CFU of L.m. (DActA Listeria) were injected intravenously into sterile
PBS (see Supplemental Experimental Procedures).Immunity 45, 1205–1218, December 20, 2016 1215
Microarray
Cells sorted by flow cytometry were collected in complete RPMI and pelleted,
lysed in Buffer RLT (RNeasy Kit, QIAGEN), and frozen at80C until they were
processed for RNA. The NuGENOvation PicoWTA V2 Kit was used to process
1 ng RNA per sample into cDNA amplified by single-primer isothermal amplifi-
cation. The Encore Biotin Module (NuGEN) was used to fragment and label the
cDNA with biotin. Hybridization cocktails were prepared as recommended by
NuGEN and hybridized to Affymetrix Mouse Gene 1.0 ST arrays overnight. Ar-
rays were washed and stained with Affymetrix Fluidics Station FS450 and the
GeneChip Hybridization, Wash, and Stain Kit and scanned by the GeneChip
Scanner 3000 7G with Autoloader. Raw data files (DAT and CEL) were gener-
ated in Affymetrix GeneChip Command Console software and are available
at GEO: GSE90471. Data were analyzed with GenePattern software (Broad
Institute), and pre-DCandCDPdatasetswere obtained frompublic databases.
t-SNE Analysis
Single-cell analysis using the t-SNE algorithm was done on flow cytometry
data in the online platform provided by Cytobank (see Supplemental Experi-
mental Procedures).
Single-Cell qPCR
Single cells were sorted by flow cytometry, cDNA was amplified with the
CellsDirect One-Step qRT-PCR Kit (ThermoFisher), and qPCR was run on a
BioMark HD (Fluidigm) with the help of Taqman probes (Life Technologies)
for the genes indicated in Figure 2. The 45 targeted genes were analyzed
against an average of three housekeeping genes: Hprt, ActB, and Gapdh.
Analysis was done with the help of Gene-E software (Broad Institute) (see
Supplemental Experimental Procedures).
qPCR
qPCR was carried out in duplicate for samples sorted from three independent
sorting experiments. Primers used for testing Zbtb46 were 50-AGAGAG
CACATGAAGCGACA-30 (forward) and 50-CTGGCTGCAGACATGAACAC-30
(reverse). Results were normalized against b-actin: 50-ATGCTCCCCGGG
CTGTAT-30 (forward) and 50-CATAGGAGTCCTTCTGACCCATTC-30 (reverse).
Adoptive Transfer
For adoptive transfer of cells sorted by flow cytometry, 3.33 105 cells of each
population were collected in complete RPMI, centrifuged, resuspended in
120 ml of RPMI alone, and injected intravenously into each CD45.1+ congenic
recipient. For whole-BM transfers, single-cell suspensions of BM were
depleted of red blood cells by exposure to RBC lysis buffer (Life technologies)
and counted. 40 3 106 whole-BM cells from Sfpi1+/+ or Sfpi1+/ mice were
transferred into B16-GM-CSF-treated congenic CD45.1+ mice on day 9 and
analyzed on day 11 after tumor injection. For L.m.-infected recipients, 20 3
106 whole-BM cells were transferred into congenic CD45.1+ recipients 2 hr
before intravenous L.m. infection.
Statistical Analysis
Data were analyzed for statistical significance by unpaired Student’s t tests.
Differences were considered significant at p < 0.05 (*p < 0.05; **p < 0.005;
***p < 0.0005; ****p < 0.00005; ns, non-significant).
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